2001
DOI: 10.1016/s0304-3940(00)01733-x
|View full text |Cite
|
Sign up to set email alerts
|

A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
32
0
5

Year Published

2002
2002
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(41 citation statements)
references
References 16 publications
4
32
0
5
Order By: Relevance
“…Furthermore, based on our present findings, we propose that a combined therapy with antioxidant and high energetic agents should provide to pre-clinical genetically individuals at risk to suffer PD a means to delay or to prevent motor symptoms and/or frank PD-ARJP disorders, as those encounter in Antioquia, Colombia (Pineda-Trujillo et al, 2001, 2009. These data may contribute to a better understanding of the inherent nutritional status, genetic predisposition and environmental agents as causative factors of PD.…”
Section: Resultssupporting
confidence: 53%
“…Furthermore, based on our present findings, we propose that a combined therapy with antioxidant and high energetic agents should provide to pre-clinical genetically individuals at risk to suffer PD a means to delay or to prevent motor symptoms and/or frank PD-ARJP disorders, as those encounter in Antioquia, Colombia (Pineda-Trujillo et al, 2001, 2009. These data may contribute to a better understanding of the inherent nutritional status, genetic predisposition and environmental agents as causative factors of PD.…”
Section: Resultssupporting
confidence: 53%
“…The hereditary nature of ARJP implicates a number of mutations in the genes encoding the proteins parkin, PINK1, LRRK2, and DJ-1 as the cause of dopaminergic neurodegeneration (1-4). A variety of deletion, truncation, and point mutations distributed throughout the park2 gene, which encodes the protein parkin, have been reported in ARJP patients (1,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18).…”
Section: Autosomal Recessive Juvenile Parkinson Disease (Arjp)mentioning
confidence: 99%
“…The hereditary nature of ARJP implicates a number of mutations in the genes encoding the proteins parkin, PINK1, LRRK2, and DJ-1 as the cause of dopaminergic neurodegeneration (1-4). A variety of deletion, truncation, and point mutations distributed throughout the park2 gene, which encodes the protein parkin, have been reported in ARJP patients (1,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18).Parkin functions as a ubiquitin ligase (E3) and belongs to a family of RBR (RING-between-RING) ubiquitin ligase enzymes involved in proteosome-mediated protein degradation (19 -21). The currently accepted domain architecture of parkin, deduced from multiple sequence alignment, shows that the C terminus of the protein is characterized by two ϳ50-residue RING (really interesting new gene) domains separated by a 51-residue IBR (In-Between-RING) domain (22,23).…”
mentioning
confidence: 99%
“…A more detailed description of the Paisas has been published elsewhere. [41][42][43][44][45] Racial admixture estimations, 43 evolutionary reconstruction using phylogenetic methods, 44,46 genotyping of specific chromosomal Y and mitochondrial markers 46 and the presence of strong founder effects for some deleterious mutations resulting in neurodegenerative diseases, such as Early Onset Alzheimer Disease (PS-1 E280A), CADASIL (notch3 C455R) and Parkinson Disease (Parkin Cys212Tyr), [47][48][49][50][51][52] all support the conclusion that this community exhibits the features of a genetic isolate.…”
Section: Sample Ascertainment and Clinical Diagnosismentioning
confidence: 99%